Artrya (AYA) Stock Price, News & Analysis

Company Overview

Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease. It offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: A$78.67 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: Automobiles And Trucks
• Current Symbol: ASX:AYA
• CIK: N/A
• Web: www.artrya.com
• Phone: 61 8 6478 7816
• Fax: N/A
• Employees: 19,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.18)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$14 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -52.07%
• Return on Assets: -34.45%

Debt

• Debt-to-Equity Ratio: 5.65
• Current Ratio: 7.34
• Quick Ratio: 18.20

Sales & Book Value

• Annual Sales: A$197 thousand
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.21 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 79,910,000
• Free Float: N/A
• Market Cap: A$78.67 million
• Optionable: Not Optionable
• Beta: 0.71